Allecra’s Exblifep secures FDA approval for cUTI treatment
The FDA approved Exblifep (cefepime/enmetazobactam) based on a comprehensive set of clinical data showing the drug's efficacy against…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
28 Feb 24
The FDA approved Exblifep (cefepime/enmetazobactam) based on a comprehensive set of clinical data showing the drug's efficacy against…
28 Feb 24
The BTD for NVL-520 is based on the preliminary safety and activity of NVL-520 in heavily pretreated patients…
27 Feb 24
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
26 Feb 24
In the trial, a 16-week course of omalizumab enhanced the quantity of peanut, tree nut, egg, milk, and…
26 Feb 24
The typhoid vaccine was developed under a collaborative effort between the company and the International Vaccine Institute and…
26 Feb 24
This raise comes just 4 months after their $30M Series B, and is one of the largest funding…
26 Feb 24
The collaboration will focus on developing a next-generation, hyper-personalised primary care model for clinicians and patients.
23 Feb 24
Blueprint Medicines will be paid a purchase price of $15m, of which $10m is due upon Rigel's first…
23 Feb 24
First-Ever Program in the Country to Offer At-Home Self-Collection of Samples for HPV Testing
22 Feb 24
A Phase 1 dosage expansion clinical trial combining IO-202 with azacitidine is presently enrolling newly diagnosed CMML patients…